EWMA 2017, held in Amsterdam, provided a unique and interesting look at the European Advanced Wound Care market - showcasing products approved for the European market but not yet launched in the US. Europe has always been a breeding ground for innovative medical devices, and has long served as a gateway for companies looking to bring new devices to the US. While some of these companies have no desire to enter the US market, many look to the US market with high expectations. It is the largest medical device market in the world, with one language and one regulatory and reimbursement system, and is much less complicated than the European market where distribution partnerships and regulatory approvals are sometimes needed for each country.To read more about Advanced Wound Care growth for the US and EU and high tech advanced wound care products emerging from Europe that could be competing in the US market, please click to download the
Biologics and single-use NPWT devices’ strong growth helps boost sluggish advanced dressing performance.
By Susan Paquette, VP Wound and
Lennart Stadler, Senior Analyst Wound
For Q317, according to BioMedGPS’ SmartTRAK Financial Dashboard, WW Advanced Wound Care (AWC) revenues for Advanced Dressings, External Devices and Biologics grew in spite of a weak performance with market leaders.
Topics: Wound Care-Advanced Wound Care
Doug Devens has joined SmartTRAK to cover new Hemostats & Sealants area including Surgical Matrices
SmartTRAK is happy to introduce you to the newest member of the SmartTRAK team, Doug Devens, PhD. Doug will be heading up our Biosurgery efforts, including our newest segment in Advanced Wound Care, Hemostats and Sealants; and Surgical Matrices – both Hernia and Breast. The new Hemostats & Sealants area covers over 27 companies and 55 products on a global basis, with several currently in development.